Newellis Inc

NUWE
0,1705
-0,0355 (-17,23%)
04 Mag 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202415:00GLOBENuwellis Receives USPTO Notice of Patent Allowance for..
01/5/202400:09GLOBENuwellis Announces Closing of $2.7 Million Public Offering
30/4/202422:41GLOBENuwellis, Inc. To Report First Quarter 2024 Financial..
26/4/202415:17GLOBENuwellis Announces Pricing of $2.7 Million Public Offering
09/4/202415:00GLOBENuwellis Announces Launch of Ultrafiltration Therapy Using..
11/3/202422:08EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
07/3/202415:08GLOBELate-Breaking Data Highlighting Benefits of Ultrafiltration..
06/3/202418:02EDGAR2Form 8-K - Current report
05/3/202414:00GLOBENuwellis, Inc. Announces Fourth Quarter and Full Year 2023..
05/3/202412:05IHMARKETNEWSU.S. Futures Dip, Crude Oil Fluctuates
27/2/202415:00GLOBENuwellis, Inc. To Report Fourth Quarter and Full Year 2023..
22/2/202413:58GLOBENuwellis’ Distribution Partner, SeaStar Medical, Receives..
20/2/202423:06GLOBENuwellis, Inc. Reports Inducement Grants Under Nasdaq..
20/2/202414:42GLOBENuwellis to Announce Late-Breaking Clinical Data and Host..
08/2/202423:19EDGAR2Form S-1/A - General form for registration of securities..
06/2/202415:07EDGAR2Form 8-K - Current report
06/2/202415:00GLOBENew Case Series Demonstrates Potential of Aquadex Therapy..
09/1/202423:30EDGAR2Form 8-K/A - Current report: [Amend]
08/1/202415:24EDGAR2Form 8-K - Current report
04/1/202422:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202421:05GLOBENuwellis Receives FDA Clearance for an Additional Dual Lumen..
13/12/202322:05EDGAR2Form 8-K - Current report
28/11/202314:00GLOBENew Real-World Data Highlight the Clinical Benefits of..
14/11/202322:30GLOBENuwellis, Inc. Reports Inducement Grants Under Nasdaq..
07/11/202316:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202314:15EDGAR2Form 8-K - Current report
07/11/202314:00GLOBENuwellis, Inc. Announces Third Quarter 2023 Financial..
01/11/202321:15EDGAR2Form 8-K - Current report
01/11/202313:00GLOBENuwellis Announces Board of Directors Transition
31/10/202313:00GLOBENuwellis’ Strategic Partner, SeaStar Medical, Receives FDA..
18/10/202322:15GLOBENuwellis, Inc. To Announce Third Quarter 2023 Financial..
17/10/202322:30EDGAR2Form 8-K - Current report
17/10/202322:15GLOBENuwellis Announces Closing of $2.25 Million Public Offering..
13/10/202314:30GLOBENuwellis Announces Pricing of $2.25 Million Public Offering..
10/10/202314:30EDGAR2Form 8-K - Current report
10/10/202314:00GLOBENuwellis Provides Regulatory Update on SeaStar Medical’s..
06/10/202322:50EDGAR2Form POS462C - Post-effective amendment to registration..
05/10/202315:27EDGAR2Form AW - Amendment Withdrawal Request
04/10/202323:29EDGAR2Form POS AM - Post-Effective amendments for registration..
02/10/202306:15EDGAR2Form EFFECT - Notice of Effectiveness
29/9/202314:56EDGAR2Form S-1/A - General form for registration of securities..
11/9/202322:15GLOBENuwellis to Present at the Gilmartin Group Emerging Growth..
06/9/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202322:12EDGAR2Form 3 - Initial statement of beneficial ownership of..
18/8/202322:56EDGAR2Form 8-K - Current report
08/8/202318:09EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202314:25EDGAR2Form 8-K - Current report
08/8/202314:15EDGAR2Form 8-K - Current report
08/8/202314:15GLOBENuwellis, Inc. Announces Second Quarter 2023 Financial..
08/8/202314:00GLOBENuwellis Announces Plan for CFO Transition
Apertura: 0,215 Min: 0,1674 Max: 0,232
Chiusura: 0,206

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network